Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis

Multiple Sclerosis Journal

Volumn 17, Issue 10, 2011, Pages 1194-1201

  Vercellino, Marco ^a   Grifoni, Silvia ^b   Romagnolo, Alberto ^b   Masera, Silvia ^b   Mattioda, Alessandra ^b   Trebini, Claudia ^b   Chiavazza, Carlotta ^b   Caligiana, Laura ^b   Capello, Elisabetta ^c   Mancardi, Giovanni Luigi ^c   Giobbe, Dario ^a   Mutani, Roberto ^b   Giordana, Maria Teresa ^b   Cavalla, Paola ^b  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

grey matter; inflammation; microglia; multiple sclerosis; neuroprotection; progranulin

Indexed keywords

PROGRANULIN;

ADULT; AGED; ARTICLE; BRAIN TISSUE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; DEMYELINATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MACROPHAGE; MALE; MICROGLIA; MULTIPLE SCLEROSIS; PROTEIN EXPRESSION; RELAPSE; VIRUS ENCEPHALITIS; WOUND HEALING;

EID: 80053226483     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511406164     Document Type: Article

References (24)

1. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain. 2005 ; 128: 2705-2712 (Pubitemid 41552953)
2. Vercellino M, Plano F, Votta B, Mutani R, Giordana MT, Cavalla P. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol. 2005 ; 64: 1101-1107
3. Ahmed Z, Mackenzie IR, Hutton ML, Dickson DW. Progranulin in frontotemporal lobar degeneration and neuroinflammation. J Neuroinflammation. 2007 ; 4: 7-7
4. Eriksen JL, Mackenzie IR. Progranulin: normal function and role in neurodegeneration. J Neurochem. 2008 ; 104: 287-297 (Pubitemid 350293866)
5. Van Damme P, Van Hoecke A, Lambrechts D, Vanacker P, Bogaert E, van Swieten J, et al. Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival. J Cell Biol. 2008 ; 181: 37-41 (Pubitemid 351519762)
6. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006 ; 442: 916-919 (Pubitemid 44285946)
7. He Z, Bateman A. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med. 2003 ; 81: 600-612 (Pubitemid 37357675)
8. He Z, Ong CH, Halper J, Bateman A. Progranulin is a mediator of the wound response. Nat Med. 2003 ; 9: 225-229 (Pubitemid 36227726)
9. Zhu J, Nathan C, Jin W, Sim D, Ashcroft GS, Wahl SM, et al. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell. 2002 ; 111: 867-878 (Pubitemid 36106407)
10. Bö L, Mörk S, Kong PA, Nyland H, Pardo CA, Trapp BD. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol. 1994 ; 51: 135-146 (Pubitemid 24147480)
11. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998 ; 338: 278-285 (Pubitemid 28065253)
12. Van der Valk P, De Groot CJA. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol Appl Neurobiol. 2000 ; 26: 2-10 (Pubitemid 30145301)
13. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol. 2001 ; 50: 121-127
14. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996 ; 46: 907-911
15. Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, Comabella M, et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology. 2009 ; 73: 1914-1922
16. Mackenzie IR, Baker M, Pickering-Brown S, Hsiung GY, Lindholm C, Dwosh E, et al. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain. 2006 ; 129: 3081-3090 (Pubitemid 44684527)
17. Mukherjee O, Pastor P, Cairns NJ, Chakraverty S, Kauwe JS, Shears S, et al. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann Neurol. 2006 ; 60: 314-322 (Pubitemid 44520234)
18. Baker CA, Manuelidis L. Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A. 2003 ; 100: 675-679 (Pubitemid 36126111)
19. Naphade SB, Kigerl KA, Jakeman LB, Kostyk SK, Popovich PG, Kuret J. Progranulin expression is upregulated after spinal contusion in mice. Acta Neuropathol. 2010 ; 119: 123-133
20. Yin F, Banerjee R, Thomas B, Zhou P, Qian L, Jia T, et al. Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J Exp Med. 2010 ; 207: 117 S1-128 S4
21. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain. 2007 ; 130: 1089-1104 (Pubitemid 47355604)
22. De Riz M, Galimberti D, Fenoglio C, Piccio LM, Scalabrini D, Venturelli E, et al. Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes. Neurosci Lett. 2010 ; 469: 234-236
23. Hohlfeld R. Neurotrophic cross-talk between the nervous and immune systems: relevance for repair strategies in multiple sclerosis?. J Neurol Sci. 2008 ; 265: 93-96
24. Zeis T, Graumann U, Reynolds R, Schaeren-Wiemers N. Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain. 2008 ; 131: 288-303